To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...
Do you want to know how you can develop new drugs to combat drug-resistant microorganisms? How to find a way to imprint the immune system to increase tolerance? Reducing the side effects of treatment ...